Celanese Completes Sale of Oxo Products and Derivatives Businesses
Celanese Corporation announced that it completed the sale of its oxo products and derivatives businesses, including European Oxo GmbH ("EOXO"), a joint venture between Celanese AG and Degussa AG, to Advent International, for the purchase price of EUREUR480 million, which is approximately USD $630 million at current exchange rates. The transaction excludes limited business activity in Turkey, which remains subject to customary regulatory review.
The sale includes oxo and derivatives businesses at Celanese's Oberhausen, Germany, and Bay City, Texas, facilities as well as portions of its Bishop, Texas, facility. The sale also includes EOXO's facilities within the Oberhausen and Marl, Germany, plants, and the 50 percent interest in the EOXO joint venture previously owned by Degussa.
Most read news
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.